ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Capital expenditures 2016–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$886,000FY2024 · since FY2016: $11.5M → $886,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $886,000 | -81.1% |
| FY2023 | $4.7M | -84.1% |
| FY2022 | $29.5M | +244.0% |
| FY2021 | $8.6M | +266.3% |
| FY2020 | $2.3M | +47.0% |
| FY2019 | $1.6M | -59.3% |
| FY2018 | $3.9M | -84.1% |
| FY2017 | $24.6M | +114.2% |
| FY2016 | $11.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice